AS ASPI ASP Isotopes Inc. Загрузка... : Бычьи и медвежьи мнения аналитиков

Author opened a watchlist-sized starter in ASPI, a Si-28 isotope supplier for quantum chips; author's own characterization is "watchlist size," no meaningful position.

Author endorses a past call on ASPI that gained 40% but does not state a current position or forward catalyst, so it is indexed as watch.

Buy ASPI as a current portfolio holding; isotope separation across silicon-28, enriched uranium, and helium positions ASPI at the intersection of semiconductor manufacturing, nuclear energy, and strategic materials — all resource-constrained in the author's chaos thesis.

Author discloses current portfolio holding in ASPI, positioned within a conviction book themed around defense systems and AI infrastructure.

SEC FOIA logs reveal ongoing investigations for listed companies, indicating regulatory scrutiny but no directional view expressed.

Author discloses current ownership of ASPI as part of a Defense/Compute-themed personal portfolio, implying long conviction in defense AI and compute.

The author lists a crowd-sourced basket of stocks already up 2-6 times but expresses no personal forward-looking directional view, merely endorsing followers' conviction with a vague "so do I" that lacks a specific trade thesis.

ASP Isotopes shares rose 9.7% after announcing a strategic HALEU supply partnership, but the Seeking Alpha Quant Rating remains a Strong Sell due to valuation and profitability concerns.

Helium is irreplaceable for MRI cooling, semiconductor fabrication, quantum computing, and rocketry. About one-third of global supply vanished after Iranian strikes on Qatar's Ras Laffan plant. Prices have more than doubled. ASP Isotopes has acquired a major new helium asset in South Africa (Free State) with an estimated NPV north of $3 billion versus a ~$600 million market cap, offering a relatively pure-play helium exposure.